Angioimmunoblastic T‐cell lymphoma after acute myeloid leukemia: Alleged common pathogenesis. A case report and literature review

Abstract

Abstract The genomic landscape of AITL is characterized by mutation of epigenetic modifiers. This gene expression pattern resembles myeloid diseases and shows a potential role for hypomethylating agents as possible therapy for AITL.

Keywords

• angioimmunoblastic T‐cell lymphoma
• DNMT3A
• epigenetic modifiers
• myeloid malignancies
• TET2